Lupin gets USFDA tentative nod for Abacavir, Dolutegravir and Lamivudine Tablets for Oral Suspension for HIV-1 infection Ruchika Sharma24 Jan 2025 12:30 PM ISTMumbai: Global pharma major Lupin Limited has announced that it has received tentative approval from the United States Food and Drug Administration...
Lupin bags tentative USFDA okay for Abacavir, Dolutegravir, Lamivudine Tablets for Oral Suspension for HIV treatment Ruchika Sharma6 Dec 2024 2:56 PM ISTMumbai: Global pharma major Lupin Limited has announced that it has received tentative approval from the United States Food and Drug...
Former and current use of abacavir linked to higher incidence of MACE: Study Dr. Kamal Kant Kohli26 Aug 2024 8:00 PM ISTCurrent or previous use of the antiretroviral drug (ARV) abacavir was associated with an elevated risk of major adverse cardiovascular events (MACE)...
Viatris gets USFDA tentative nod for paediatric formulation of Abacavir, Dolutegravir, Lamivudine for children with HIV Ruchika Sharma5 Sept 2023 3:54 PM ISTBangalore: Viatris Inc., a global healthcare company, today announced U.S. Food and Drug Administration (FDA) tentative approval for a New Drug...
USFDA tentative nod to Aurobindo Pharma's generic FDC drug to treat HIV in children Ruchika Sharma17 Aug 2023 1:30 PM ISTAurobindo has capacities in their FDA approved plant to meet the market demand for this product and commercial production will commence in Q3 FY24.
Novel HIV drug formulation could improve treatment outcomes for children globally Isra Zaman4 Aug 2023 9:30 AM ISTResearchers at the University of Colorado Anschutz Medical Campus have helped confirm the dosing, safety and effectiveness of a drug formulation...
Cipla, DNDi unveil 4-in-1 ARV formulation for kids with HIV Ruchika Sharma15 Jun 2022 12:00 PM ISTThe '4-in-1' combination contains an antiretroviral combination that is recommended by the World Health Organization (WHO) as an alternative...
NPPA directs pharma firms to provide PTR, MAT details for 29 formulations Medical Dialogues Team12 July 2021 2:06 PM ISTNew Delhi: In order to take appropriate action for ceiling price fixation under the provisions of the DPCO, 2013, the National Pharmaceutical...
